首页> 外文期刊>Pathobiology: journal of immunopathology, molecular and cellular biology >Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells.
【24h】

Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells.

机译:人肝癌细胞在新生C57BL / 6小鼠肝脏中的存活时间延长,并导致细胞异体注射,尤其是肝天然杀伤性T细胞的激活。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To investigate the fate of human hepatocellular carcinoma (HCC) in the livers of newborn mice and the resulting cellular rejection. METHODS: Two HCC cell lines (HepG2 and HCCLM3) labeled with DMAHAS were orthotopically transplanted to newborn and adult mice with or without low-dose cyclosporin A (CsA) treatment (10 mg/kg). The fate of tumor xenografts was examined and the resulting cellular response was investigated. RESULTS: Tumor xenografts survived in newborn mice for > 4 weeks, with a delayed lymphocyte infiltration mediated by CD4+ T, CD8+ T and NK1.1+ cells. In contrast, the xenografts survived in adults < 8-10 days with an acute cellular rejection by CD8+T cells, NK1.1+ cells, macrophages or neutrophils. Orthotopic transplantation of human HCC xenografts elicited a strong cytotoxic response in newborn mice (p < 0.05), and selective T/NK1.1+ cell deletion in vitro suggested that such effector cells were mainly CD8+ T cells. Moreover, tumor xenografts induced a rapid activation of hepatic natural killer T (NKT) cells in both newborn and adult mice with enhanced secretion of IL-4 and IFN-gamma in serum and subsequent NKT-like cytotoxicity. The rapid activation of NKT cells could be efficiently suppressed by low-dose CsA treatment, possibly in a CD1d-independent manner. CONCLUSION: Our data suggest that the livers of newborn mice were more suitable for the survival of xenografts than those of adult mice. Cell-mediated tumor xenorejection in newborn mice was different from that in adults, and hepatic NKT cells may play an important role in early tumor xenorejection.
机译:目的:研究新生小鼠肝脏中人类肝细胞癌(HCC)的命运及其引起的细胞排斥反应。方法:将两种标记有DMAHAS的HCC细胞系(HepG2和HCCLM3)原位移植到新生小鼠和成年小鼠中,分别接受或不接受低剂量环孢菌素A(CsA)(10 mg / kg)处理。检查了肿瘤异种移植的命运并研究了所产生的细胞反应。结果:新生小鼠的肿瘤异种移植存活超过4周,CD4 + T,CD8 + T和NK1.1 +细胞介导的淋巴细胞浸润延迟。相反,异种移植物在成年<8-10天后存活,并被CD8 + T细胞,NK1.1 +细胞,巨噬细胞或嗜中性粒细胞急性排斥。人肝癌异种移植物的原位移植在新生小鼠中引起强烈的细胞毒性反应(p <0.05),体外选择性T / NK1.1 +细胞缺失提示这种效应细胞主要是CD8 + T细胞。此外,肿瘤异种移植物在新生和成年小鼠中均诱导肝天然杀伤性T细胞(NKT)的快速活化,并增强了血清中IL-4和IFN-γ的分泌,继而产生类似NKT的细胞毒性。 NKT细胞的快速激活可以通过低剂量CsA处理有效地抑制,可能以CD1d独立的方式进行。结论:我们的数据表明,新生小鼠的肝脏比成年小鼠的肝脏更适合异种移植的存活。新生小鼠中细胞介导的肿瘤异种注射与成年小鼠不同,并且肝NKT细胞可能在早期肿瘤异种注射中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号